Literature DB >> 26537664

A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.

Igor A Altman1, Raymond E Kleinfelder2, John G Quigley3, William J Ennis1, Caterina P Minniti4.   

Abstract

Sickle cell leg ulcers (SCLUs) are a common complication of sickle cell disease (SCD). Patients who develop ulcers appear to have a more severe haemolysis-associated vasculopathy than individuals who do not develop them, and manifest other complications such as priapism and pulmonary hypertension. SCLUs are slow to heal and often recur, affecting both the emotional and physical well-being of patients. Here we summarise what is known about the pathophysiology of SCLUs, describe available treatment options and propose a treatment algorithm.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Pathophysiology; Sickle cell leg ulcers; Sickle cell wounds; Treatment algorithm

Mesh:

Substances:

Year:  2015        PMID: 26537664      PMCID: PMC7949888          DOI: 10.1111/iwj.12522

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  69 in total

1.  Treatment of painful sickle cell leg ulcers with topical opioids.

Authors:  Samir K Ballas
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers.

Authors:  F Lionnet; C Bachmeyer; K Stankovic; P L Tharaux; R Girot; S Aractingi
Journal:  Br J Haematol       Date:  2008-07-29       Impact factor: 6.998

3.  Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence.

Authors:  Andrea Clare; Michael FitzHenley; June Harris; Ian Hambleton; Graham R Serjeant
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

4.  Sickle cell disease and leg ulcers.

Authors:  Barry Ladizinski; Andrea Bazakas; Nisha Mistry; Afsaneh Alavi; R Gary Sibbald; Richard Salcido
Journal:  Adv Skin Wound Care       Date:  2012-09       Impact factor: 2.347

5.  Antithrombin III concentrate for treatment of chronic leg ulcers in sickle cell-beta thalassemia: a pilot study.

Authors:  E Cacciola; R Giustolisi; R Musso; A Longo; E Cacciola
Journal:  Ann Intern Med       Date:  1989-09-15       Impact factor: 25.391

6.  Oral zinc sulphate in sickle-cell ulcers.

Authors:  G R Serjeant; R E Galloway; M C Gueri
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

Review 7.  New techniques for wound debridement.

Authors:  Brijesh M Madhok; Kathryn Vowden; Peter Vowden
Journal:  Int Wound J       Date:  2013-02-19       Impact factor: 3.315

8.  A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.

Authors:  V Falanga; M Sabolinski
Journal:  Wound Repair Regen       Date:  1999 Jul-Aug       Impact factor: 3.617

Review 9.  Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections?

Authors:  Tianhong Dai; Mark S Vrahas; Clinton K Murray; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2012-02       Impact factor: 5.091

10.  Abnormal venous function in patients with homozygous sickle cell (SS) disease and chronic leg ulcers.

Authors:  J S Mohan; J E Vigilance; J M Marshall; I R Hambleton; H L Reid; G R Serjeant
Journal:  Clin Sci (Lond)       Date:  2000-06       Impact factor: 6.124

View more
  7 in total

1.  Sickle Cell Anemia and Comorbid Leg Ulcer Treated With Curative Peripheral Blood Stem Cell Transplantation.

Authors:  Joseph L Connor; Caterina P Minniti; John F Tisdale; Matthew M Hsieh
Journal:  Int J Low Extrem Wounds       Date:  2017-01-09       Impact factor: 2.057

Review 2.  Leg Ulcers in Sickle-Cell Disease: Treatment Update.

Authors:  Jean-Benoît Monfort; Patricia Senet
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-04-24       Impact factor: 4.730

3.  Use of a National Electronic Health Record Network to Describe Characteristics and Healing Patterns of Sickle Cell Ulcers.

Authors:  Anna Flattau; Hanna Gordon; Giacomo Vinces; William J Ennis; Caterina P Minniti
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

4.  Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.

Authors:  Hezekiah Isa; Samuel Adegoke; Anazoeze Madu; Abdul-Aziz Hassan; Chinatu Ohiaeri; Reuben Chianumba; Biobele Brown; Emmanuel Okocha; Ngozi Ugwu; Ijeoma Diaku-Akinwumi; Titilope Adeyemo; Aisha Kuliya-Gwarzo; Livingstone Dogara; Haliru Lawal; Yohanna Tanko; Adama Ladu; Umar Kangiwa; Lilian Ekwem; Seyi Oniyangi; Tambi Wakama; Domic Umoru; Olaniyi Olanrewaju; Norah Akinola; Uche Nnebe-Agumadu; Samuel Asala; Adekunle Adekile; John Olaniyi; Raphael Sangeda; Obiageli Nnodu
Journal:  Blood Cells Mol Dis       Date:  2020-04-23       Impact factor: 2.372

5.  Sickle Cell Disease Clinical Trials and Phenotypes.

Authors:  Chinedu A Ezekekwu; Taiwo R Kotila; Titilola S Akingbola; Guillaume Lettre; Victor R Gordeuk; Richard S Cooper; Michael R DeBaun; Baba Inusa; Bamidele O Tayo
Journal:  J Trop Dis Public Health       Date:  2018-04-08

6.  Brief topical sodium nitrite and its impact on the quality of life in patients with sickle leg ulcers.

Authors:  Joseph L Connor; Joseph A Sclafani; Gregory J Kato; Matthew M Hsieh; Caterina P Minniti
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

7.  Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview.

Authors:  Josimare Aparecida Otoni Spira; Eline Lima Borges; Antônio Carlos Martins Guedes; Paula Gabriela Ribeiro Andrade; Vera Lúcia de Araújo Nogueira Lima
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.